What is Optimize Health?
Established in 2019, Optimize Health operates at the intersection of digital health and enterprise software, providing a comprehensive platform for reimbursable remote patient monitoring. By integrating affordable, high-quality medical devices with an intuitive technology interface, the company empowers healthcare providers to monitor patient health outcomes proactively while simultaneously containing operational costs. This dual-focus on clinical efficacy and financial sustainability has established Optimize Health as a critical partner for modern healthcare organizations seeking to modernize their patient engagement strategies through scalable, data-driven solutions.
How much funding has Optimize Health raised?
Optimize Health has raised a total of $18M across 1 funding round:
Series B
$18M
Series B (2023): $18M with participation from Daher Capital, OpenView Partners, Navigate Ventures, Escalate Capital Partners, Atento Capital, SOSV, Jumpstart Capital, Bonfire Ventures, Foundry Capital, and 500 Global
Key Investors in Optimize Health
Navigate Ventures
Navigate Ventures specializes in investing in top B2B Enterprise SaaS companies, particularly those that are AI-enabled, providing a risk-mitigated strategy that accelerates growth and secures institutional capital.
Escalate Capital Partners
Escalate Capital Partners is a prominent investment firm that focuses on rapidly growing later-stage companies in the technology, software, and healthcare sectors, providing capital solutions that are less dilutive to management.
Jumpstart Capital
Jumpstart Capital invests in innovative companies that are transforming healthcare through advanced technology and streamlined workflows, specifically targeting platforms for remote patient monitoring and decision support.
What's next for Optimize Health?
With the successful closure of this major enterprise-level funding, Optimize Health is well-positioned to transition into its next phase of growth. The strategic deployment of this capital will likely focus on deepening the integration of its platform within existing electronic health record systems and expanding its suite of reimbursable monitoring tools. As the demand for decentralized care continues to rise, the company is expected to leverage its strengthened balance sheet to capture additional market share, enhance its AI-driven analytics capabilities, and further streamline the administrative workflows that currently challenge healthcare providers. This trajectory suggests a sustained focus on long-term value creation for both clinical stakeholders and the patients they serve.
See full Optimize Health company page
